Close

NIH Holding Prize Competition for the Complement-Animal Research in Experimentation (Complement-ARIE) Challenge

The NIH Common Fund is beginning a strategic planning process for a potential Complement-Animal Research In Experimentation (Complement-ARIE) program concept to catalyze the development, standardization, validation, and use of New Approach Methodologies (NAMs) that will more accurately model human outcomes. As part of the NIH’s Complement-ARIE strategic planning working group, the Office of Strategic Coordination (Common Fund) intends to publish a prize competition announcement to solicit entries for new methods and approaches that would complement, make more efficient, or, in some cases, replace traditional animal models, transforming the way biomedical researchers conduct basic, translational, and clinical sciences.

Interdisciplinary collaboration drives creativity and innovation, and teams of people coming from different disciplines and backgrounds can create out-of-the-box solutions that would otherwise never be imagined. By integrating various perspectives towards developing solutions, researchers can develop NAMs that provide high-quality, reproducible findings that can address significant biomedical questions with the highest relevance to human biology.

This Notice is being provided to inform potential solvers about the upcoming opportunity to compete in the Complement-ARIE Challenge. Publication of the Challenge announcement and launch of the submission portal are planned for November 7, 2023. Potential applicants are encouraged to sign up for the Complement-ARIE listserv to receive updates about the Challenge. The estimated submission deadline for submissions is January 11, 2024.

The NIH Common Fund intends to award a total prize purse of up to $1,000,000 which will be awarded to up to 20 winners (up to $50,000 each). To be eligible to win prizes, participants must be led by a Team Leader who is a citizen or permanent resident of the United States or be an entity incorporated in and maintaining a primary place of business in the United States.

For more information, please view the announcement.